Synairgen announces global strategic partnership with Ashfie

/PRNewswire/ -- Synairgen plc (LSE: SNG), the respiratory company developing SNG001 (inhaled interferon-beta or IFN-beta) for the treatment of COVID-19 as...

Related Keywords

United Kingdom , Mary Conway , Richard Marsden , John Ward , Duncan Monteith , Jessica Hodgson , Ratko Djukanovic , Freddie Barnfield , Greg Flynn , Richard Hennings , Geoff Nash , Donna Davies , Brooke Clarke , James Black , Kate Bannatyne , Mary Jane Elliott , Lucy Featherstone , Numis Securities Limited Joint Broker , Head Of Communications , United Kingdom National Institute For Health Research , Us National Institute Of Health , Drug Administration , Npatient Solutions , Consilium Strategic Communications Financial Media , University Of Southampton Professors Sir Stephen Holgate , Mkc Strategies Llc Us Media Relations , Urgent Public Health , Ashfield Engage , Chief Commercial Officer , Global President , Fast Track , National Institute , Health Research , Chief Executive , Chief Financial , Joint Broker , Charlie Beeson , Corporate Finance , Sunil De Silva , Securities Limited , Strategic Communications , Financial Media , Investor Relations , Jane Elliott , United Kingdom Based , Southampton Professors Sir Stephen Holgate , Medical Affairs , Event Experiences , Synairgen Plc ,